Company / Return on Equity (ROE)
GoodRx Holdings, Inc. Return on Equity (ROE) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
4.9%
FY2025
5-year range
-4.0% / 4.9%
FY2021-FY2025
Trend
+118.6%
vs FY2024
Sector context
#149 of 277
Information Technology
What the data says
At 4.9%, GoodRx Holdings, Inc.'s return on equity (roe) ranks #149 of 277 in the Information Technology sector. Return on Equity (ROE) has increased for 3 consecutive years, from -4.0% in FY2022 to 4.9% in FY2025.
Based on SEC 10-K filings.
4.9% in FY2025 with a 5-year CAGR of +46.2%.
Improved from -1.2% to 4.9% over the past 2 years.
Information Technology sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +9.0pp
- 5-Year Change
- +46.2pp
- 10-Year Change
- -
Sector benchmark
#149 of 277 in Information TechnologyTop 54% of 277This company 4.9% Sector average 4.3%
▼
+15.3% above sector average
Key checks
Key Insights
- GoodRx Holdings, Inc.'s return on equity (roe) has grown for 3 consecutive years.
- In FY2025, return on equity (roe) increased 118.6% year-over-year.
- Currently 0.7pp above the Information Technology sector average.
- Lowest return on equity (roe) in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 4.9% | +118.6% |
| FY2024 | 2.3% | +294.8% |
| FY2023 | -1.2% | +71.2% |
| FY2022 | -4.0% | -32.6% |
| FY2021 | -3.0% | +92.6% |
| FY2020 | -41.3% | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026